Literature DB >> 31777643

Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

Yasodha Krishnasamy1, Monika Gooz1, Li Li1, John J Lemasters1,2, Zhi Zhong1.   

Abstract

The pathogenesis of non-alcoholic steatohepatitis (NASH) is poorly understood. Here, relationships between mitochondrial depolarization (mtDepo) and mitochondrial homeostasis were studied in a mouse model of NASH. C57BL/6 mice were fed a Western diet (high fat, fructose and cholesterol) for 2 weeks, 2 months and 6 months, and livers were harvested for histology and biochemical analysis. Hepatic mtDepo was evaluated by intravital multiphoton microscopy. After Western diet feeding, mixed hepatic micro- and macrovesicular steatosis and leukocyte infiltration occurred at 2 weeks and continued to increase afterwards. ALT release, mild necrosis, apoptosis, and ballooning degeneration were present at 2 and 6 months. Smooth muscle α-actin expression increased at 2 weeks and longer, and increased collagen-I expression and mild fibrosis occurred at 6 months. After feeding Western diet for 2 weeks and longer, mtDepo appeared in 50-70% hepatocytes, indicating mitochondrial dysfunction at an early stage of NASH. mtDepo can initiate mitophagy, and mitophagic markers increased at 2 and 6 months. Concurrently autophagic processing became impaired. Oxidative phosphorylation proteins, mitochondrial biogenesis signals, and proteins associated with mitochondrial fission and fusion decreased after 2 months and longer of Western diet. Proinflammatory and profibrotic signaling (NLRP3 inflammasome activation, expression of IL-1, osteopontin and TGF-β1) also increased in association with mitochondrial stress/dysfunction after Western diet feeding. Taken together, we show that hepatic mtDepo occurs early in mice fed a Western diet, followed by increased mitophagic burden, suppressed mitochondrial biogenesis and dynamics, and mitochondrial depletion. These novel mitochondrial alterations in NASH most likely play an important role in promoting steatosis, inflammation, and progression to fibrosis. IJPPP
Copyright © 2019.

Entities:  

Keywords:  Mitochondrial depolarization; mitochondrial biogenesis; mitochondrial dynamics; mitophagy; non-alcoholic fatty liver disease

Year:  2019        PMID: 31777643      PMCID: PMC6872485     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  78 in total

Review 1.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

2.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

Review 3.  Nutritional therapy for nonalcoholic fatty liver disease.

Authors:  Paola Dongiovanni; Claudia Lanti; Patrizia Riso; Luca Valenti
Journal:  J Nutr Biochem       Date:  2015-10-23       Impact factor: 6.048

4.  Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats.

Authors:  A Ramadan; Nehal Afifi; Nemat Z Yassin; Rehab F Abdel-Rahman; Sahar S Abd El-Rahman; Hany M Fayed
Journal:  Chem Biol Interact       Date:  2018-05-05       Impact factor: 5.192

Review 5.  Mitochondrial permeability transition: a common pathway to necrosis and apoptosis.

Authors:  Jae-Sung Kim; Lihua He; John J Lemasters
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

6.  Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.

Authors:  Janice M Huss; Inés Pineda Torra; Bart Staels; Vincent Giguère; Daniel P Kelly
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Fructose, insulin resistance, and metabolic dyslipidemia.

Authors:  Heather Basciano; Lisa Federico; Khosrow Adeli
Journal:  Nutr Metab (Lond)       Date:  2005-02-21       Impact factor: 4.169

8.  Acute ethanol causes hepatic mitochondrial depolarization in mice: role of ethanol metabolism.

Authors:  Zhi Zhong; Venkat K Ramshesh; Hasibur Rehman; Qinlong Liu; Tom P Theruvath; Yasodha Krishnasamy; John J Lemasters
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 9.  Mitochondrial dynamics and mitochondrial quality control.

Authors:  Hong-Min Ni; Jessica A Williams; Wen-Xing Ding
Journal:  Redox Biol       Date:  2014-11-20       Impact factor: 11.799

Review 10.  Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (Type 3).

Authors:  John J Lemasters
Journal:  Redox Biol       Date:  2014-06-12       Impact factor: 11.799

View more
  11 in total

1.  Drp1-mediated mitochondrial fission promotes carbon tetrachloride-induced hepatic fibrogenesis in mice.

Authors:  Shulin Shan; Zhidan Liu; Shuai Wang; Zhaoxiong Liu; Zhengcheng Huang; Yiyu Yang; Cuiqin Zhang; Fuyong Song
Journal:  Toxicol Res (Camb)       Date:  2022-05-23       Impact factor: 2.680

Review 2.  Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease.

Authors:  Raghu Ramanathan; Ahmad Hassan Ali; Jamal A Ibdah
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 3.  NAFLD: Mechanisms, Treatments, and Biomarkers.

Authors:  Fatiha Nassir
Journal:  Biomolecules       Date:  2022-06-13

4.  Livogrit Prevents Methionine-Cystine Deficiency Induced Nonalcoholic Steatohepatitis by Modulation of Steatosis and Oxidative Stress in Human Hepatocyte-Derived Spheroid and in Primary Rat Hepatocytes.

Authors:  Acharya Balkrishna; Vivek Gohel; Priya Kumari; Moumita Manik; Kunal Bhattacharya; Rishabh Dev; Anurag Varshney
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.

Authors:  Anita M van den Hoek; Lars Verschuren; Nicole Worms; Anita van Nieuwkoop; Christa de Ruiter; Joline Attema; Aswin L Menke; Martien P M Caspers; Sridhar Radhakrishnan; Kanita Salic; Robert Kleemann
Journal:  Cells       Date:  2020-09-01       Impact factor: 6.600

Review 6.  Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation.

Authors:  Paul Middleton; Nikhil Vergis
Journal:  Therap Adv Gastroenterol       Date:  2021-07-27       Impact factor: 4.409

Review 7.  Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?

Authors:  Xinyu Li; Quyan Zhang; Zeyu Wang; Quan Zhuang; Mingyi Zhao
Journal:  Front Mol Biosci       Date:  2022-02-03

Review 8.  Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease.

Authors:  Aigli-Ioanna Legaki; Ioannis I Moustakas; Michalina Sikorska; Grigorios Papadopoulos; Rallia-Iliana Velliou; Antonios Chatzigeorgiou
Journal:  Curr Obes Rep       Date:  2022-05-02

9.  Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation.

Authors:  Yanni Zhou; Dan Long; Ying Zhao; Shengfu Li; Yan Liang; Lin Wan; Jingyao Zhang; Fulai Xue; Li Feng
Journal:  Cell Death Dis       Date:  2022-08-06       Impact factor: 9.685

10.  Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Ruibing Li; Sam Toan; Hao Zhou
Journal:  Aging (Albany NY)       Date:  2020-03-26       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.